|
A Strategy for Improvement of Recombinant Pharmaceutical Industry Using Animal Cell Culture Technology
|
| Kyu Ho Bang and Kyeong Soo Kim |
| Yakhak Hoeji 2021;65(1):1-9 |
|
|
|
A Comparative Study on Health Insurance Fees Related to Community Pharmacists’ Services in Korea and Japan
|
| Sun-Hong Kwon, Eun-Hae Sohn, and Hye-Lin Kim |
| Yakhak Hoeji 2021;65(1):10-16 |
|
|
|
Strain, Age, and Gender Differences in Response to Lipopolysaccharide (LPS) Animal Model of Sepsis in Mice
|
| Ivan Gahima, Eric Twizeyimana, Edson LuckGonzales, Chilly Gay Remonde, Se Jin Jeon, and Chan Young Shin |
| Yakhak Hoeji 2021;65(1):17-22 |
|
|
|
Standardization and validation of molecular size distribution test for human immunoglobulin products in Korea
|
| Chan Woong Choi, Ka Young Kim, Ho-Jin Song, Kiwon Han, Seungwan Jee, and Jaeok Kim |
| Yakhak Hoeji 2021;65(1):23-30 |
|
|
|
Rapid and Sensitive Quantification Method of Sphingosine and Sphingosine-1-phosphate in Human Serum by Ultra High-Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)
|
| Seonghoon Na and Hye-Ran Yoon |
| Yakhak Hoeji 2021;65(1):31-40 |
|
|
|
Cuttlebone Shows Anti-inflammatory Activity Via Suppression of NF-κB Activation in LPS-induced RAW 264.7 Macrophages
|
| Geum Seon Lee and Tae Jin Kang |
| Yakhak Hoeji 2021;65(1):41-45 |
|
|
|
An Analysis of the Factors Related to EU GMP Non-compliance - Focusing on Active Substance, Human Medicinal Product -
|
| Jieun Lim and Hea-Kyoung Cho |
| Yakhak Hoeji 2021;65(1):46-55 |
|
|
|
Consideration of Legal Implications of the Patent Dispute Judgement on Solifenacin Salt Change
|
| Miyeon Jeong, Kwang Joon Kim, and Wonjae Lee |
| Yakhak Hoeji 2021;65(1):56-63 |
|
|
Yakhak Hoeji 2021;65(1):1-63
